Evidence map›Paper›PMID 31718504›Full record

SynthesisStroke2020

Journal Initiatives to Enhance Preclinical Research: Analyses of

F Daniel Ramirez, Richard G Jung, Pouya Motazedian, Dylan Perry-Nguyen, Pietro Di Santo, Zachary MacDonald, Aisling A Clancy, Alisha Labinaz, Steven Promislow, Trevor Simard and 5 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Stroke, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Moving towards less biased research.BMJ open science · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

F Daniel RamirezFrom the Division of Cardiology (F.D.R., P.D.S., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
Richard G JungCAPITAL Research Group (F.D.R., R.G.J., P.M., D.P.-N., P.D.S., A.L., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
Pouya MotazedianCAPITAL Research Group (F.D.R., R.G.J., P.M., D.P.-N., P.D.S., A.L., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
Dylan Perry-NguyenCAPITAL Research Group (F.D.R., R.G.J., P.M., D.P.-N., P.D.S., A.L., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
Pietro Di SantoFrom the Division of Cardiology (F.D.R., P.D.S., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
Zachary MacDonaldFaculty of Medicine (R.G.J., P.M., D.P.-N., Z.M.), University of Ottawa, ON, Canada.
Aisling A ClancyDepartment of Obstetrics and Gynecology (A.A.C.), University of Ottawa, ON, Canada.
Alisha LabinazCAPITAL Research Group (F.D.R., R.G.J., P.M., D.P.-N., P.D.S., A.L., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
Steven PromislowFrom the Division of Cardiology (F.D.R., P.D.S., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
Trevor SimardFrom the Division of Cardiology (F.D.R., P.D.S., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
Steeve ProvencherPulmonary Hypertension Research Group, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (S. Provencher, S.B.), Université Laval, Québec City, Canada.
Sébastien BonnetPulmonary Hypertension Research Group, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (S. Provencher, S.B.), Université Laval, Québec City, Canada.
Ian D GrahamSchool of Epidemiology and Public Health (F.D.R., P.D.S., I.D.G., G.A.W.), University of Ottawa, ON, Canada.
George A WellsCardiovascular Research Methods Centre (G.A.W.), University of Ottawa Heart Institute, ON, Canada.
Benjamin HibbertFrom the Division of Cardiology (F.D.R., P.D.S., S. Promislow, T.S., B.H.), University of Ottawa Heart Institute, ON, Canada.
University of Ottawa · CAUniversité Laval · CACentre Hospitalier Universitaire de Bordeaux · FRHarvard University · US

Funding

CIHR FDN 143237
6 · The paper itself

Abstract

Background and Purpose- Preclinical research using animals often informs clinical trials. However, its value is dependent on its scientific validity and reproducibility, which are, in turn, dependent on rigorous study design and reporting. In 2011,

Indexed as

StrokeTranslational Research, BiomedicalFemaleHumansMaleReproducibility of Resultsanimal modelbiasbiomedical researchresearch designsample size

Identifiers

PMID31718504
PMCPMC6924942
OpenAlexW2987736646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.